Paper Details

  1. Home
  2. Paper Details

[Pharmacovigilance and teratovigilance].

Author: BiollazJérôme, BuclinThierry, LivioFrançoise

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Some data have been produced that modulate the safety profile of drugs, such as cardiovascular events under erythropoietins, macular oedema under rosiglitazone, vascular and renal complications of aprotinine, drawbacks of long-term linezolide administration, intracranial haemorrhage under tipranavir, anyphylaxis with pegaptanib, cardiototoxicity of imatinib, lymphomas with infliximab, bone pain and aches under bisphosphonates, cardiovascular events related to methylphenidate, congenital anomalies ascribed to paroxetine and lamotrigine, neonatal pulmonary hypertension related to serotonine reuptake inhibitors, infantile respiratory depression under promethazine.
Paper Details　
Original Abstract of the Article :
While 2006 did not record as many upsetting revelations of adverse drug reactions as the previous few years, still some data have been produced, which modulate the safety profile of drugs and deserve the attention of the prescribers: cardiovascular events under erythropoietins, macular oedema under ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/17357693

データ提供：米国国立医学図書館（NLM）

Pharmacovigilance and Teratovigilance: Navigating the Drug Safety Landscape

The [pharmacovigilance and teratovigilance] landscape is a complex desert, with a constant need to monitor and assess the safety of medications. This research provides a detailed overview of various drug safety concerns, including cardiovascular events under erythropoietins, macular oedema under rosiglitazone, and congenital anomalies ascribed to paroxetine and lamotrigine. This study highlights the importance of ongoing surveillance and vigilance in identifying and mitigating potential risks associated with medications. It also underscores the need for careful consideration of drug safety profiles, especially during pregnancy.

Drug Safety: A Constant Journey of Vigilance

This research serves as a reminder that the journey of drug safety is a continuous one, with new challenges emerging constantly. It emphasizes the importance of careful monitoring and vigilance in identifying and mitigating potential risks associated with medications. This study, like a vigilant camel scout traversing the desert, helps us stay informed and aware of the potential risks and benefits of medications.

Staying Informed: Your Guide to Safe Medication Use

Just like a camel navigating the desert, we need to be mindful of the risks and benefits of medications. This research highlights the importance of staying informed about potential side effects and talking to your healthcare provider about any concerns. By understanding the drug safety landscape, we can make informed decisions about our health and well-being. Remember, knowledge is power, especially when it comes to safe medication use.

Dr.Camel's Conclusion

This study provides a comprehensive overview of various drug safety concerns, underscoring the importance of ongoing surveillance and vigilance in identifying and mitigating potential risks. This research, like a beacon in the desert, guides us toward a safer and more informed use of medications.

Date :
  1. Date Completed 2007-08-21
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

17357693

DOI: Digital Object Identifier

17357693

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.